Imunon is developing new medicines that harness the building blocks of life to work in harmony with the body’s immune system. Imunon creates proprietary immunology and DNA-based platforms and products aimed at some of the world’s most difficult-to-treat conditions.
people lose their lives to vaccine-preventable diseases every year - our clinical development of anti-cancer nucleic acid-based therapies and nucleic acid vaccines for infectious diseases and cancer is about being bold and solving the world's biggest problems. Because every person deserves the opportunity to live a full life.
combined years of leadership experience in the biotech industry
key partners, including the world’s most respected research institutions
products in the pipeline with an addressable market worth $15B+
October 23–25, 2023 | Boston, MA
Dr. Khursheed Anwer will deliver an oral presentation on A DNA-Based Vaccine Technology Independent Of A Virus Or Device
If you’re interested in partnering with us on an upcoming project, we’d love to hear from you.